Fuji renames Daiichi subsidiary

By AuntMinnie.com staff writers

January 17, 2007 -- Japanese film and technology company Fujifilm has applied its corporate branding to its recently acquired Daiichi Radioisotope Laboratories (DRL) subsidiary, with the division to be known as Fujifilm RI Pharma, effective April 1.

Fujifilm, the parent company of film and PACS company Fujifilm Medical, bought DRL in October 2006 from Japanese drug maker Daiichi Pharmaceutical. The division develops and manufactures radiopharmaceuticals used in nuclear medicine procedures in Japan.

DRL had revenues of 17.22 billion yen ($142.7 million) for its fiscal year ended March 31, 2006, with 420 employees. Its products include radiopharmaceuticals for brain, cardiac, and bone diagnostic procedures, as well as therapeutic agents for thyroid disease.

In announcing the name change, Fuji said the new identity indicates the division's status as a member of the Fuji group of companies. Fuji said that Fujifilm RI Pharma will play an important role in the company's expansion in the medical business, which Fuji regards as one of its most important fields.

By AuntMinnie.com staff writers
January 17, 2007

Fuji acquires cardiac PACS firm ProSolv, January 11, 2007

Amerinet awards two contracts to Fujifilm, January 10, 2007

Fuji wins Premier CR contract, December 15, 2006

Fujifilm Australia wins public healthcare contract, December 8, 2006

Fuji touts CR mammo, moves into flat-panel DR with RSNA launches, November 29, 2006

Copyright © 2007 AuntMinnie.com


To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking